Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study

Leukemia relapse and chronic graft-versus-host disease (cGVHD) are still major obstacles of allogeneic hematopoietic stem cell transplantation (allo-HSCT). The numbers and activity of natural killer (NK) and T-regulatory cells can be increased post-transplantation by exposure to interleukin-2 (IL-2)...

詳細記述

保存先:
書誌詳細
出版年:Oncoimmunology
主要な著者: Zhao, Xiang-Yu, Zhao, Xiao-Su, Wang, Yu-Tong, Chen, Yu-Hong, Xu, Lan-Ping, Zhang, Xiao-Hui, Han, Wei, Chen, Huan, Wang, Yu, Yan, Chen-Hua, Wang, Feng-Rong, Wang, Jing-Zhi, Liu, Kai-Yan, Chang, Ying-Jun, Huang, Xiao-Jun
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2016
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215224/
https://ncbi.nlm.nih.gov/pubmed/28123892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1250992
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料